Protara Therapeutics

Protara Therapeutics TARA Stock

$2.34   0.862068%
Add to favorites
Market Cap
$144.07M
LOW - HIGH [24H]
$2.28 - $2.41
VOLUME [24H]
$1.15M
P/E Ratio
0
Earnings per share
-$1.39
ISIN
US74365U1079
Price   Prediction

Protara Therapeutics Price Chart

Sorry, that's all we've gotfor now...

Protara Therapeutics (TARA) stock price today is 2.34 USD on Tech Market Middle (+0.86% on the day). Updated .

Protara Therapeutics TARA Financial and Trading Overview

Protara Therapeutics stock price 2.34 USD
Previous Close 2.32 USD
Open 2.31 USD
Bid 2.92 USD x 200
Ask 5.12 USD x 200
Day's Range 2.31 - 2.41 USD
52 Week Range 2.09 - 7.82 USD
Volume 632.22K USD
Avg. Volume 1.03M USD
Market Cap 143.46M USD
Beta (5Y Monthly) 1.542
PE Ratio (TTM) N/A
EPS (TTM) -1.39 USD
Forward Dividend & Yield N/A (0%)
Ex-Dividend Date N/A
1y Target Est 25.33 USD

TARA Valuation Measures

Enterprise Value 18.23M USD
Trailing P/E N/A
Forward P/E -1.315225
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) N/A
Price/Book (mrq) 0.99064624
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -0.215

Trading Information

Protara Therapeutics Stock Price History

Beta (5Y Monthly) 1.542
52-Week Change -65.42%
S&P500 52-Week Change 10.51%
52 Week High 7.82 USD
52 Week Low 2.09 USD
50-Day Moving Average 2.83 USD
200-Day Moving Average 4.33 USD

TARA Share Statistics

Avg. Volume (3 month) 1.03M USD
Avg. Daily Volume (10-Days) 703.2K USD
Shares Outstanding 61.57M
Float 57.36M
Short Ratio 2.01
% Held by Insiders 2.20%
% Held by Institutions 74.91%
Shares Short 3.24M
Short % of Float 5.48%
Short % of Shares Outstanding 5.40%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio N/A
Last Split Factor 1:40

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2025
Most Recent Quarter (mrq) September 30, 2026
Next Fiscal Year End December 31, 2026

Profitability

Profit Margin 0%
Operating Margin (ttm) 0%
Gross Margin 0%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -35.35%
Return on Equity (ttm) -57.40%

Income Statement

Revenue (ttm) N/A
Revenue Per Share (ttm) N/A
Quarterly Revenue Growth (yoy) N/A
Gross Profit (ttm) N/A
EBITDA -84860000 USD
Net Income Avi to Common (ttm) -78445000 USD
Diluted EPS (ttm) -1.39
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 127.05M USD
Total Cash Per Share (mrq) 2.06 USD
Total Debt (mrq) 2.44M USD
Total Debt/Equity (mrq) 1.73 USD
Current Ratio (mrq) 9.01
Book Value Per Share (mrq) 2.352

Cash Flow Statement

Operating Cash Flow (ttm) -72124000 USD
Levered Free Cash Flow (ttm) -43868248 USD

Profile of Protara Therapeutics

Country United States
State NY
City New York
Address 345 Park Avenue South
ZIP 10010
Phone 646 844 0337
Website https://www.protaratx.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 46

Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy, which is in Phase II clinical trial for the treatment of non-muscle invasive bladder cancer and lymphatic malformations. It is also developing intravenous choline chloride, an investigational phospholipid substrate replacement therapy for patients receiving parenteral nutrition and fluids. The company is headquartered in New York, New York.

Q&A For Protara Therapeutics Stock

What is a current TARA stock price?

Protara Therapeutics TARA stock price today per share is 2.34 USD.

How to purchase Protara Therapeutics stock?

You can buy TARA shares on the Tech Market Middle exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Protara Therapeutics?

The stock symbol or ticker of Protara Therapeutics is TARA.

Which industry does the Protara Therapeutics company belong to?

The Protara Therapeutics industry is Biotechnology.

How many shares does Protara Therapeutics have in circulation?

The max supply of Protara Therapeutics shares is 61.57M.

What is Protara Therapeutics Price to Earnings Ratio (PE Ratio)?

Protara Therapeutics PE Ratio is now.

What was Protara Therapeutics earnings per share over the trailing 12 months (TTM)?

Protara Therapeutics EPS is -1.39 USD over the trailing 12 months.

Which sector does the Protara Therapeutics company belong to?

The Protara Therapeutics sector is Healthcare.

Protara Therapeutics TARA included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
us US Tech Composite IXIC US 24429.89 USD —
+0.42
7.16B USD — 24225.3 USD — 24538.78 USD — — 7.16B USD —
us US Tech Global Market Composite NQGM US 1839.01 USD —
+0.18
— — 1830.2 USD — 1855.92 USD — — — —
us US Tech Health Care IXHC US 1324.44 USD —
-0.63
— — 1322.85 USD — 1342.46 USD — — — —
us US Tech Capital Market Composite RCMP US 108.78 USD —
+0.08
— — 108.35 USD — 109.95 USD — — — —
$2.2T
Total marketcap
$74.25B
Total volume
BTC 58.10%   •   ETH 10.01%
Dominance
Select currency